Skip to content

Evaluation of a bundled care approach to preventing surgical site infections post caesarean section in an Australian Rural Hospital

Evaluation of a bundled care approach to preventing surgical site infections post caesarean section in an Australian Rural Hospital

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12619001001189
Enrollment
710
Registered
2019-07-15
Start date
2017-12-01
Completion date
2018-12-31
Last updated
2019-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

Elective and non-elective caesarean section (CS) rates have been increasing in Australia over the past 20 years. Increasing antenatal morbidity, has meant that surgical site infection (SSI) post CS is an important issue effecting Australian women. Populations most impacted include low socioeconomic and regional communities where high rates of antenatal comorbidity augment the incidence of SSI. Despite a recent trend towards supporting the development of evidence based bundled approaches to SSI reduction, there remains paucity in data proving efficacy and supporting bundle implementation. This study aimed to develop, implement and assess an evidence based caesarean infection prevention “CIP” bundled intervention to reduce SSI rates following CS in a high risk rural population. The study is a pre-post intervention study with 3 phases and included all women undergoing CS at a regional referral hospital between December 1st 2016 and December 31st 2018. A 12 month retrospective pre-intervention review identified all women who developed a post CS SSI. A comprehensive literature review informed the development of the intervention, which was implementation in December 2017. Prospective data collection for a subsequent 12 month period was collected on all women who underwent CS with pre and post comparative data analysis.

Interventions

The intervention is comprised of a caesarean infection prevention "CIP" bundle that was developed and implemented across the study population. The CIP bundle had five elements including: 1) Identification of women at risk of surgical site infection (SSI) post caesarean section (CS) - Antenatal identification and education administered by booking midwives and medical officers 2) Pre-operative site skin preparation protocol - No shaving, clipping if required in the operating theatre by the medical

The intervention is comprised of a caesarean infection prevention "CIP" bundle that was developed and implemented across the study population. The CIP bundle had five elements including: 1) Identification of women at risk of surgical site infection (SSI) post caesarean section (CS) - Antenatal identification and education administered by booking midwives and medical officers 2) Pre-operative site skin preparation protocol - No shaving, clipping if required in the operating theatre by the medical officer - Neutral detergent bed bath prior to CS administered by the attending midwife 3) Antibiotics prophylaxis administered pre-operatively - Cephazolin 2g Intravenously 15-60 minutes before knife to skin administered by Anaesthetics - Clindamycin 600mg Intravenously if known MRSA carrier or cephalosporin allergy 4) Operative site skin preparation - 2% Chlorhexidine gluconate and 70% alcohol for skin preparation - Applied by the attending medical officer or scrub nurse prior to surgical draping 5) Negative pressure wound therapy (NPWT) for Body Mass Index (BMI) > 35 - Applied intra-operatively and left on incision wound for 7 days - Women with BMI < 35 have standard wound dressings applied The intervention begins prior to surgery and concludes at the end of the surgical procedure or upon removal of negative pressure dressings at day 7 for women with a BMI over 35. Participants are followed up until 30 days post operatively. The intervention is the responsibility of all clinical midwives, obstetric medical staff, anaesthetics and the Infection Control Clinical Nurse Consultant (CNC). Surveillance and adherence data is collected using a multifaceted process including review of all patients undergoing CS in the study period, emergency department encounters and hospital admissions for wound complications within a 30 day post operative period.

Sponsors

Tamworth Regional Referral Hospital - Tamworth
Lead SponsorHospital

Study design

Allocation
Non-randomised trial
Intervention model
Other
Primary purpose
Prevention
Masking
Open (masking not used)

Eligibility

Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

All women undergoing CS 12 months prior to implementation of the Bundle and all women undergoing CS 12 months post implementation of the bundle

Exclusion criteria

There are no exclusion criteria in this study

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 28, 2026